The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • Luouth@lemmy.world
    3·
    2 days ago

    Wow guys, thanks a lot for the informative comments! I love how Lemmy isn’t just a minefield of memes and jokes in the comments like Reddit